| |
|
|
|
|
|
|
|||
|
Blood, 15 September 2008, Vol. 112, No. 6, pp. 2575-2578. Prepublished online as a Blood First Edition Paper on July 10, 2008; DOI 10.1182/blood-2008-02-140681.
TRANSPLANTATION Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors1 Université Paris Descartes, Faculté de Médecine, Centre National de la Recherche Scientifique UMR 8147 and 2 Inserm U580, Paris, France; 3 Hôpital Necker-Enfants Malades, Paris, France; and 4 Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Mexico
Mechanisms of protection against autoimmune diseases by transplantation of autologous hematopoietic progenitors remain poorly defined. We recently demonstrated that, unlike medullary hematopoietic stem cells (HSCs), mobilized hematopoietic progenitors (HPCs) stimulate peripheral Foxp3+ regulatory T cell (Treg)–expansion through cell-contact activation of Notch signaling and through as yet undetermined soluble factor(s), distinct from TGF-β1. Herein we identified one such soluble factor as granulocyte macrophage–colony stimulating factor (GM-CSF), which is produced at higher levels by HPCs than HSCs and whose neutralization significantly reduces the growth-promoting effect of HPCs on Treg. Treg express a functional GM-CSF receptor
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||